Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges

Roxan F. C. P. A. Helderman, Daan R. Loke, Pieter J. Tanis, Jurriaan B. Tuynman, Wim Ceelen, Ignace H. de Hingh, Kurt van der Speeten, Nicolaas A. P. Franken, Arlene L. Oei, H. Petra Kok, Johannes Crezee*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number3430
Number of pages24
JournalCancers
Volume13
Issue number14
DOIs
Publication statusPublished - Jul 2021

Keywords

  • peritoneal carcinomatosis
  • peritoneal metastasis
  • cytoreductive surgery (CRS)
  • hyperthermic intraperitoneal chemotherapy (HIPEC)
  • HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
  • COLORECTAL PERITONEAL CARCINOMATOSIS
  • RECURRENT OVARIAN-CANCER
  • CYTOREDUCTIVE SURGERY
  • TISSUE DISTRIBUTION
  • SYSTEMIC CHEMOTHERAPY
  • CHEMOPERFUSION HIPEC
  • COLONIC ANASTOMOSIS
  • XENOGRAFT MODEL
  • GASTRIC-CANCER

Cite this